Resultado de búsqueda
8 de oct. de 2024 · Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Chairman and CEO Howard Berman, Ph.D. has been recognized as a PharmaVoice 100 winner in the category of Biotech Pathfinders .
8 de oct. de 2024 · HOUSTON, October 08, 2024 -- (BUSINESS WIRE)-- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance...
10 de oct. de 2024 · Coya Therapeutics Chairman and CEO Howard Berman Selected for PharmaVoice 100. October 10, 2024; Share this post. We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells.
8 de oct. de 2024 · Coya Therapeutics (NASDAQ: COYA) anuncia que su Presidente y CEO, Howard Berman, Ph.D., ha sido reconocido como un ganador del PharmaVoice 100 en la categoría de Biotech Pathfinders. Esta lista anual honra a las personas más inspiradoras en la industria de las ciencias de la vida.
8 de oct. de 2024 · Howard Berman, CEO of Coya Therapeutics, honored as a PharmaVoice 100 winner for his impactful leadership in the biotechnology industry.
23 de sept. de 2024 · By combining the medicines, Howard Berman, co-founder and CEO of Coya Therapeutics, says he thinks Coya can better treat these complex immune-based diseases. Read more.
Hace 3 días · By combining the medicines, Howard Berman, co-founder and CEO of Coya Therapeutics, says he thinks Coya can better treat these complex immune-based diseases. Berman joined the Houston Innovators Podcast in April of 2023 to discuss taking Coya public and his passion for the company's mission. Read more.
Anuncio
relacionado con: Howard BermanRead Customer Reviews & Find Best Sellers. Free, Easy Returns On Millions Of Items. Grab Exciting Offers and Discounts On an Array Of Products From Popular Brands.
